UP Pharmaceutical & Medical Device Policy 2023: Complete Guide
What Is the Policy?
The Uttar Pradesh Pharmaceutical & Medical Device Policy, 2023 covers bulk drugs/APIs, formulations, biologics, nutraceuticals, and medical device manufacturing, plus dedicated Pharma Parks and Medical Device Parks. It is administered by the Infrastructure & Industrial Development Department, with Invest UP as the facilitating agency.
Key Incentives
| What | Details |
|---|---|
| Capital subsidy | For eligible manufacturing units |
| Interest subsidy | On term loans for the project |
| SGST | Reimbursement |
| Stamp duty | Exemption |
| Electricity duty | Exemption |
| Regulatory approval costs | Reimbursement of WHO-GMP, USFDA, CE, and CDSCO certification costs โ a feature that distinguishes this policy from most other UP sector policies |
Eligibility
- New units and expansions in bulk drugs/APIs, formulations, biologics, nutraceuticals, or medical devices
- Park developers setting up Pharma Parks or Medical Device Parks
- Common facility centre operators within these parks
Are There Dedicated Parks?
Yes โ two, at different stages:
- Medical Device Park: at Yamuna Expressway (YEIDA), in Gautam Buddh Nagar district, supported under the Central Medical Device Parks scheme, with common testing and sterilisation facilities โ the district's flagship pharma-sector asset.
- Pharma Park: at Lalitpur (Bundelkhand), under development.
How Does This Fit With Central Schemes?
The policy converges with the Central government's PLI for bulk drugs, PLI for medical devices, and the promotion of bulk drug and medical device parks schemes.
What About Environmental Clearance?
Does the Older 2018 Policy Still Apply?
The 2018 Pharmaceutical Industry Policy remains relevant for units with existing eligibility under it; new applications should use this 2023 policy instead.
How to Apply
- Confirm which incentive heads (capital, interest, SGST, duty exemptions, regulatory reimbursement) apply to your unit type
- If setting up in a red-category activity like API manufacturing, start UPPCB consent and effluent planning immediately, alongside land
- Approach the Infrastructure & Industrial Development Department / Invest UP as the nodal point
Frequently Asked Questions
What makes this policy different from most other UP sector policies?
Reimbursement of regulatory approval costs โ WHO-GMP, USFDA, CE, and CDSCO certification โ is a distinguishing feature not commonly found in other UP state sector policies.
Should a new pharma unit apply under the 2018 policy or the 2023 policy?
New applications should use the 2023 policy. The 2018 Pharmaceutical Industry Policy remains relevant only for units that already had eligibility established under it.
Need help with your UP Pharmaceutical & Medical Device Policy application?
ClaimDesk (A NorthStar Advisors brand, Noida) helps you confirm eligibility, work out the applicable incentive heads, and start UPPCB engagement alongside your application. The first conversation is completely free.
MSMEUP.com is independent information & tools โ free, and not run by any consultancy. ClaimDesk is a separate, private consultancy (a NorthStar Advisors brand) for those who want professional filing help; its fee is for that service, not a government charge, and using it is entirely optional โ MSMEUP's guides and tools work the same with or without it.
Official portal: niveshmitra.up.gov.in Administered by: Infrastructure & Industrial Development Dept. / Invest UP Last reviewed: Aug 2026
This page summarizes publicly available scheme information. For the current official notification, application form and exact eligibility conditions, always confirm on the portal above before applying or filing a claim.